Loading
Life sciences · Journal article
Journal of Infection · September 17, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
The World Health Organization (WHO) priority pathogens list, particularly those classified as "critical" and "high" priority, serves as a pivotal framework guiding global efforts to combat antimicrobial resistance (AMR). This review synthesizes updated evidence on the global epidemiology, clinical burden, and antimicrobial resistance of WHO priority pathogens as of 2026. Despite extensive research on Acinetobacter baumannii, non-baumannii Acinetobacter species remain relatively understudied despite their increasing clinical relevance. This review highlights the significance of these non-baumannii species in healthcare-associated infections and their emerging resistance profiles. Additionally, the review addresses newly identified extensively drug-resistant (XDR) threats that pose significant challenges to current therapeutic options. By synthesizing the latest surveillance data, molecular resistance mechanisms, and treatment hurdles, this review aims to inform clinical management strategies, infection control practices, and public health policy development. Ultimately, this evidence-based synthesis seeks to support targeted interventions and guide future research priorities in the global fight against AMR.